摘要:
Compounds are disclosed that are useful for treating ophthalmic conditions caused by or related to production of toxic visual cycle products that accumulate in the eye, such as dry adult macular degeneration, as well as conditions caused by or related to the misfolding of mutant opsin proteins and/or the mis-localization of opsin proteins. Compositions of these compounds alone or in combination with other therapeutic agents are also described, along with therapeutic methods of using such compounds and/or compositions. Methods of synthesizing such agents are also disclosed.
摘要:
Novel hydroxy ethyl azolyl derivatives of formula (I), in which: X is hydrogen, halogen, alkyl with 1 to 4 carbon atoms or alkoxy with 1 to 4 carbon atoms; Z is halogen, alkyl with 1 to 4 carbon atoms, halogen alkyl with 1 to 4 carbon atoms and 1 to 5 halogen atoms, alkoxy with 1 to 4 carbon atoms, halogen alkoxy with 1 to 4 carbon atoms and 1 to 5 halogen atoms, nitro or possibly singly to triply, identically or differently halogen-substituted phenyl; and m is the number 0, 1, 2 or 3; and their acid-addition salts and metal salt complexes, a process for producing the novel materials and their use as microbicides in plant and material protection. Novel butenol derivatives of formula (II), novel oxiranes of formula (III) and novel ketones of formula (X) are also disclosed, together with methods for their manufacture and their use as intermediates in the synthesis of compounds of formula (I).
摘要:
Verfahren zur Herstellung von Benzolderivaten der allgemeinen Formel in der Hal ein Halogenatom, R¹ einen Kohlenwasserstoffrest mit 1 bis 18 C-Atomen, R² ein Wasserstoffatom oder einen Alkylrest mit 1 bis 6 C-Atomen und X ein Wasserstoff- oder Halogenatom bedeuten, bei dem man Toluolderivate der allgemeinen Formel in Gegenwart einer Säure der Formel R²-COOH (III) elektrochemisch oxidiert, sowie neue Benzolderivate der allgemeinen Formel in der R³ ein Wasserstoffatom oder einen R²-CO-Rest bedeutet, wobei jedoch R¹ nicht Methyl sein kann, wenn X Wasserstoff bedeutet, und neue Benzolderivate der allgemeinen Formel in der R⁴ einen verzweigten oder ringförmigen Alkylrest mit 3 bis 12 C-Atomen bedeutet, wobei jedoch R⁴ nicht Isopropyl sein kann, wenn X Wasserstoff bedeutet.
摘要:
New compounds of the general formula I: wherein R¹ is a normal or branched alkyl chain H 2n+1 C n - or a normal or branched alkoxy group H 2n+1 C n O-, n being an integer number from 1 to 12; X is a bridging group from the set: -COO-, -OCO-, -CH₂O-, -OCH₂-, -COCH₂-, -CHOHCH₂-, -CH=CH-,-CH₂CH₂-, -CHClCH₂-, -CHCNCH₂-, -CHBrCH₂-, -CHFCH₂-, -CHOCH₃CH₂-; Y is a terminal group from the set: -NO₂, -NH₂, -NCS, -Cl, -Br, -F; the cyclohexane rings are trans-1,4-disubstituted ones and the benzene rings are 1,4-disubstituted ones, and besides one of them may contain sometimes additionally a fluorine atom in position 2 or 3, k and l are integer numbers from the set: 0, 1, 2 fulfilling the condition that k+1=2 or 3; besides, if X denotes the -COO- or -OCO- group, then k+1 also may assume the value of 1 , their manufacture and liquid crystalline admixture containing them and use for electro-optical devices as dielectrics are described.
摘要:
A compound of the formula wherein X has the formula wherein ring A is phenyl, naphthyl or heterocyclic; wherein R' is hydrogen, alkyl, alkanoyl or aroyl; wherein R 2 , R 3 and R 4 , which may be the same or different, each is an electron withdrawing substituent selected from halogeno, nitro, cyano, trifluoromethyl, alkylthio, alkylsulphinyl and alkylsulphonyl or each is hydrogen, alkyl, alkoxy or dialkylamino provided that when ring A is phenyl or naphthyl at least one of R 2 , R 3 and R 4 is an electron-withdrawing substituent; wherein R 5 and R 6 , which may be the same or different, each is hydrogen, halogeno or alkyl; wherein R 7 is alkyl or halogenoalkyl; and wherein R S is carbamoyl, alkyl, cycloalkyl, alkenyl, alkynyl, halogenoalkyl, halogenoalkenyl, halogenoalkynyl, alkanoyl, alkylcarbamoyl, dialkylcarbamoyl or aroyl; or wherein R 8 is alkyl or alkenyl which bears one or more substituents selected from cyano, carbamoyl, amino, hydroxy, alkanoyl, alkoxy, alkylthio, alkenylthio, alkylsulphinyl, alkenylsulphinyl, alkylsulphonyl, alkenylsulphonyl, alkanoylamino, alkoxycarbonylamino, alkylsulphonamido, alkylamino, dialkylamino dialkylsulphamoyl, aroyl, aryl, arylthio, arylsulphinyl, arylsulphonyl, heterocyclylthio, heterocyclylsulphinyl and heterocyclylsulphonyl; or wherein R 8 has the formula wherein ring B is phenyl, naphthyl or heterocyclyl and wherein R 2 , R 3 and R 4 have any of the meanings stated above, provided that when R 7 is methyl R 8 is not also methyl.
摘要:
Lower cycloalkyl substituted-benzene derivatives, the preparation thereof and their pharmaceutical compositions. Lower cycloalkyl substituted-benzene derivatives of the formula:- wherein R' is lower cycloalkyl, R 2 is carboxy, esterified carboxy, hydroxymethyl, lower alkoxymethyl or acyloxymethyl, R 3 is lower alkanoyl or lower alkyl substituted with hydroxy, amino, lower alkylamino, di(lower)alkylamino, acylamino, lower alkoxy, acyl or acyloxy, in which the lower alkyl moieties of the di(lower)alkyl amino radical may be joined together to form a heterocyclic ring containing the nitrogen atom and the carbonyl function of the acyl radical, which is a substituent on the lower alkyl radical, may be protected, X is hydrogen or halogen, and Y is a valency bond or lower alkylene; and pharmaceutically acceptable salts thereof; pharmaceutical composition comprising the same; and methods for treatment of inflammation by administering the same to mammals.
摘要:
Lower cycloalkyl substituted-benzene derivatives, the preparation thereof and their pharmaceutical compositions. Lower cycloalkyl substituted-benzene derivatives of the formula:-
wherein R' is lower cycloalkyl, R 2 is carboxy, esterified carboxy, hydroxymethyl, lower alkoxymethyl or acyloxymethyl, R 3 is lower alkanoyl or lower alkyl substituted with hydroxy, amino, lower alkylamino, di(lower)alkylamino, acylamino, lower alkoxy, acyl or acyloxy, in which the lower alkyl moieties of the di(lower)alkyl amino radical may be joined together to form a heterocyclic ring containing the nitrogen atom and the carbonyl function of the acyl radical, which is a substituent on the lower alkyl radical, may be protected, X is hydrogen or halogen, and Y is a valency bond or lower alkylene; and pharmaceutically acceptable salts thereof; pharmaceutical composition comprising the same; and methods for treatment of inflammation by administering the same to mammals.
摘要:
The present application provides, among other things, compounds and methods for metathesis reactions. In some embodiments, provided compounds promote highly efficient and highly Z-selective metathesis. In some embodiments, provided compounds and methods are particularly useful for producing allyl alcohols. In some embodiments, provided compounds have the structure of formula I. In some embodiments, provided compounds comprise ruthenium, and a ligand bonded to ruthenium through a sulfur atom.